S Koschmieder
S Koschmieder
Unknown affiliation
Verified email at
Cited by
Cited by
The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth
LH Schmidt, T Spieker, S Koschmieder, J Humberg, D Jungen, E Bulk, ...
Journal of thoracic oncology 6 (12), 1984-1992, 2011
Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival
A Hamilton, GV Helgason, M Schemionek, B Zhang, S Myssina, EK Allan, ...
Blood, The Journal of the American Society of Hematology 119 (6), 1501-1510, 2012
Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet
T Barbui, A Tefferi, AM Vannucchi, F Passamonti, RT Silver, R Hoffman, ...
Leukemia 32 (5), 1057-1069, 2018
Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes
U Krug, C Röllig, A Koschmieder, A Heinecke, MC Sauerland, M Schaich, ...
The Lancet 376 (9757), 2000-2008, 2010
PU. 1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis
G Huang, P Zhang, H Hirai, S Elf, X Yan, Z Chen, S Koschmieder, ...
Nature genetics 40 (1), 51-60, 2008
Dysregulation of the C/EBPα differentiation pathway in human cancer
S Koschmieder, B Halmos, E Levantini, DG Tenen
Journal of clinical oncology 27 (4), 619, 2009
Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis
S Koschmieder, B Göttgens, P Zhang, J Iwasaki-Arai, K Akashi, JL Kutok, ...
Blood 105 (1), 324-334, 2005
Flt3-dependent transformation by inactivating c-Cbl mutations in AML
B Sargin, C Choudhary, N Crosetto, MHH Schmidt, R Grundler, ...
Blood, The Journal of the American Society of Hematology 110 (3), 1004-1012, 2007
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells
P Neviani, JG Harb, JJ Oaks, R Santhanam, CJ Walker, JJ Ellis, ...
The Journal of clinical investigation 123 (10), 4144-4157, 2013
JAK Inhibition Impairs NK Cell Function in Myeloproliferative NeoplasmsRuxolitinib Impairs NK Cell Function
K Schönberg, J Rudolph, M Vonnahme, S Parampalli Yajnanarayana, ...
Cancer research 75 (11), 2187-2199, 2015
IL-18 activates STAT3 in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-γ production by the stress kinase p38 and by the extracellular regulated …
U Kalina, D Kauschat, N Koyama, H Nuernberger, K Ballas, ...
The Journal of Immunology 165 (3), 1307-1313, 2000
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
H Gisslinger, C Klade, P Georgiev, D Krochmalczyk, ...
The Lancet Haematology 7 (3), e196-e208, 2020
Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry
A Kaifie, M Kirschner, D Wolf, C Maintz, M Hänel, N Gattermann, ...
Journal of hematology & oncology 9 (1), 1-11, 2016
A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia
U Steidl, C Steidl, A Ebralidze, B Chapuy, HJ Han, B Will, F Rosenbauer, ...
The Journal of clinical investigation 117 (9), 2611-2620, 2007
The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia
S Agrawal, WK Hofmann, N Tidow, M Ehrich, D Boom, S Koschmieder, ...
Blood 109 (9), 3895-3905, 2007
Dexamethasone nanomedicines for COVID-19
T Lammers, AM Sofias, R Van der Meel, R Schiffelers, G Storm, F Tacke, ...
Nature nanotechnology 15 (8), 622-624, 2020
DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia
S Agrawal, M Unterberg, S Koschmieder, U zur Stadt, U Brunnberg, ...
Cancer research 67 (3), 1370-1377, 2007
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
S Koschmieder, TI Mughal, HC Hasselbalch, G Barosi, P Valent, ...
Leukemia 30 (5), 1018-1024, 2016
S100A2 induces metastasis in non–small cell lung cancer
E Bulk, B Sargin, U Krug, A Hascher, Y Jun, M Knop, C Kerkhoff, V Gerke, ...
Clinical Cancer Research 15 (1), 22-29, 2009
Effect of transcription-factor concentrations on leukemic stem cells
F Rosenbauer, S Koschmieder, U Steidl, DG Tenen
Blood 106 (5), 1519-1524, 2005
The system can't perform the operation now. Try again later.
Articles 1–20